University of Houston Jun 9 2026  A cancer researcher at the University of Houston is reporting what makes malignant soft tissue cancer grow in children, identifying key mechanisms and molecular targets to prevent tumor progression in patients in future therapies of the fatal rhabdomyosarcoma.  A rare soft tissue cancer that has a higher incidence in young children, rhabdomyosarcoma accounts for approximately 50% of all pediatric soft tissue sarcomas, 8% of all childhood cancers and has only a